Table 4 Long term survivors after PM
Patient number | Sex | Age at PM | Histology | Grading | DFI (month) | Progression of pulmonary metastases under CHT | Number of metastases (side) | Number of PM | Survival (month) |
|---|---|---|---|---|---|---|---|---|---|
1 | m | 45 | CS | 1 | 161 | no CHT | 7 (R) + 3 (L) | 2 | 67 |
2 | m | 21 | ES | 3 | N/A | no CHT | N/A | 3 | 71 |
3 | f | 12 | OST | 3 | 50 | no CHT | 1 (R) | 1 | 88+ |
4 | m | 47 | OST | 3 | 30 | no CHT | 2 (R) | 1 | 124+ |
5 | m | 24 | OST | 3 | 1 | no progression | 2 (R) | 1 | 127+ |
6 | m | 14 | OST | 3 | 82 | no progression | 1 (L) | 1 | 151+ |
7 | m | 11 | OST | 3 | 28 | no CHT | 1 (R) | 1 | 188+ |